Transforming growth factor β enhances the expression of CD154 (CD40L) and production of tumor necrosis factor α by human T lymphocytes

This publication has 21 references indexed in Scilit:

• CD40 AND CD154 IN CELL-MEDIATED IMMUNITY
  Annual Review of Immunology, 1998
• Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion.
  The Journal of Experimental Medicine, 1995
• T helper type 1 development of naive CD4⁺ T cells requires the coordinate action of interleukin‐12 and interferon‐γ and is inhibited by transforming growth factor‐β
  European Journal of Immunology, 1994
• Role of transforming growth factor-βthe preferential induction of T helper cells of type 1 by staphylococcal enterotoxin B
  European Journal of Immunology, 1993
• Transforming growth factor-beta: recent progress and new challenges.
  The Journal of cell biology, 1992
• Differential effect of transforming growth factor β on the synthesis of T_h1‐ and T_h2‐like lymphokines by human T lymphocytes
  European Journal of Immunology, 1992
• Transforming growth factor‐β: An important mediator of immunoregulation
  The International Journal of Cell Cloning, 1991
• Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.
  The Journal of Experimental Medicine, 1987
• Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes.
  The Journal of Experimental Medicine, 1987
• Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.
  The Journal of Experimental Medicine, 1986